204257-72-7 Usage
General Description
Methyl 2-fluoro-4-iodobenzoate is a specialized chemical compound that belongs to the class of organic compounds known as fluorobenzoic acids, which are benzoic acids with a fluorine atom attached to the benzene ring. Methyl 2-fluoro-4-iodobenzoate specifically carries fluorine and iodine atoms at different positions on the benzene ring. It acts as an important intermediate in the synthesis and development of various sophisticated chemical products in fields like pharmaceuticals, biotechnology, and agrochemicals. Its molecular formula is C8H6FIO2 and molecular weight is 282.03 g/mol. This substance is not naturally occurring and needs to be synthesized in a laboratory. Its texture, color, and additional properties vary according to the conditions it is stored or synthesized under.
Check Digit Verification of cas no
The CAS Registry Mumber 204257-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,2,5 and 7 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 204257-72:
(8*2)+(7*0)+(6*4)+(5*2)+(4*5)+(3*7)+(2*7)+(1*2)=107
107 % 10 = 7
So 204257-72-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H6FIO2/c1-12-8(11)6-3-2-5(10)4-7(6)9/h2-4H,1H3
204257-72-7Relevant articles and documents
DIHYDROINDENE AND TETRAHYDRONAPHTHALENE COMPOUNDS
-
Paragraph 0114; 0162, (2018/08/09)
The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
THERAPEUTIC COMPOUNDS
-
Page/Page column 19, (2015/10/05)
The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
Compounds having activity as inhibitors of cytochrome P450RAI
-
Page column 26,52, (2010/11/29)
Compounds having Formula 8 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids.